Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Deloitte
Covington
McKinsey
Mallinckrodt
Merck
Citi
AstraZeneca
Johnson and Johnson

Generated: April 25, 2018

DrugPatentWatch Database Preview

MILPREM-400 Drug Profile

« Back to Dashboard

Which patents cover Milprem-400, and what generic alternatives are available?

Milprem-400 is a drug marketed by Medpointe Pharm Hlc and is included in one NDA.

The generic ingredient in MILPREM-400 is estrogens, conjugated; meprobamate. There are three drug master file entries for this compound. Additional details are available on the estrogens, conjugated; meprobamate profile page.
Summary for MILPREM-400
Drug patent expirations by year for MILPREM-400

US Patents and Regulatory Information for MILPREM-400

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medpointe Pharm Hlc MILPREM-400 estrogens, conjugated; meprobamate TABLET;ORAL 011045-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Farmers Insurance
Baxter
Federal Trade Commission
Deloitte
UBS
Fuji
Teva
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.